Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
Apply
Oxaliplatin, Liposomal Irinotecan, Trastuzumab
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step